You are here

  • Home
  • Online First
  • How should randomized controlled trials in epithelial ovarian cancer be interpreted?

Article info

Article menu

other Versions

Download PDFPDF
Commentary
How should randomized controlled trials in epithelial ovarian cancer be interpreted?

Authors

  • Inge Peters Department of Woman’s and Child Health and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy PubMed articlesGoogle scholar articles
  • Andrea Rosati Department of Woman’s and Child Health and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy PubMed articlesGoogle scholar articles
  • Giovanni Scambia Department of Woman’s and Child Health and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy PubMed articlesGoogle scholar articles
  • Anna Fagotti Department of Woman’s and Child Health and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Anna Fagotti, Department of Woman’s and Child Health and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; anna.fagotti{at}policlinicogemelli.it

Citation

Peters I, Rosati A, Scambia G, et al
How should randomized controlled trials in epithelial ovarian cancer be interpreted?
International Journal of Gynecologic Cancer Published Online First: 31 March 2022. doi: 10.1136/ijgc-2022-003541

Publication history

  • Received March 15, 2022
  • Accepted March 18, 2022
  • First published March 31, 2022.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.